Ismael Ortego Jamora, MD | |
2520 Valley Dr, Suite # 116, Pt Pleasant, WV 25550-2031 | |
(304) 675-5188 | |
(304) 675-3811 |
Full Name | Ismael Ortego Jamora |
---|---|
Gender | Male |
Speciality | Internal Medicine - Cardiovascular Disease |
Location | 2520 Valley Dr, Pt Pleasant, West Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033217914 | NPI | - | NPPES |
000000504 | Other | WV | BCBS |
0076037000 | Medicaid | WV | |
0222664 | Medicaid | OH | |
550737600 | Other | WV | COMMERICAL INSURANCE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 10222 (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ismael Ortego Jamora, MD Po Box 236, Pt Pleasant, WV 25550-0236 Ph: (304) 675-5188 | Ismael Ortego Jamora, MD 2520 Valley Dr, Suite # 116, Pt Pleasant, WV 25550-2031 Ph: (304) 675-5188 |
News Archive
Sorrento Therapeutics, Inc. and IGDRASOL announced today that clinical data for CynviloqTM, a non-biologic nanoparticle formulation of paclitaxel, plus gemcitabine was published for the upcoming Annual Meeting of the American Society of Clinical Oncology.
The Robert Wood Johnson Foundation (RWJF) today announced its selection of Claudia Stravato, board member and retired executive director of the Texas Panhandle Family Planning and Health Centers in Amarillo, Texas, to receive a Community Health Leaders Award. She is one of 10 extraordinary Americans who will receive the RWJF honor for 2009 at a ceremony this evening at the Mayflower Hotel in Washington, D.C.
The self-paced walking test, known as the 400-meter walk test, is effective in measuring improved physical function in postmenopausal women who have lost weight through healthy physical activity and dietary changes, according to collaborative research conducted by The University of Texas Health Science Center at Houston and The University of Pittsburgh.
Merck & Co. Inc., (operating in the United Kingdom as MSD) and Avecia Investments Limited today announced that they have entered into a definitive agreement by which Merck will acquire the biologics business of the Avecia group through a Merck affiliate (Merck Sharp & Dohme (Holdings) Limited or "MSD"). Avecia Biologics is a contract manufacturing organization with specific expertise in microbial-derived biologics. Financial details of the transaction were not disclosed.
Researchers at the University of São Paulo (USP), in Brazil, are testing a technique in mice that combines low-intensity electric current with a formulation containing nanoencapsulated chemotherapy to treat skin cancer.
› Verified 6 days ago
Dr. Stephanus Johannes Serfontein, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2418 Jefferson Ave, Pt Pleasant, WV 25550 Phone: 304-675-6835 Fax: 304-675-6849 | |
Harold Edward Ayers Jr., MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2520 Valley Dr, Suite #012, Pt Pleasant, WV 25550 Phone: 304-675-6015 Fax: 304-675-5893 | |
James Robert Toothman, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2520 Valley Dr, Pt Pleasant, WV 25550 Phone: 304-675-4340 Fax: 304-675-5893 |